{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:43:06Z","timestamp":1793846586956,"version":"4.6.1"},"reference-count":187,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T00:00:00Z","timestamp":1643846400000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["8,147,823"],"award-info":[{"award-number":["8,147,823"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008556","name":"Paul MacKall and Evanina Bell MacKall Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010849","name":"Hope For Vision","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010849","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ymthe.2020.11.029","type":"journal-article","created":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T21:25:42Z","timestamp":1606944342000},"page":"442-463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":181,"title":["Clinical Perspective: Treating RPE65-Associated Retinal Dystrophy"],"prefix":"10.1016","volume":"29","author":[{"given":"Albert M.","family":"Maguire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena M.","family":"Aleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart P.","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas S.","family":"Aleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2020.11.029_bib1","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.ophtha.2017.04.008","article-title":"Clinically focused molecular investigation of 1000 consecutive families with inherited retinal disease","volume":"124","author":"Stone","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2020.11.029_bib2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.survophthal.2004.04.003","article-title":"An overview of Leber congenital amaurosis: a model to understand human retinal development","volume":"49","author":"Koenekoop","year":"2004","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ymthe.2020.11.029_bib3","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1001\/archopht.1985.01050100078023","article-title":"Classification of congenital and early onset retinitis pigmentosa","volume":"103","author":"Foxman","year":"1985","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ymthe.2020.11.029_bib4","series-title":"Retinitis Pigmentosa","first-page":"107","article-title":"Congenital and early-onset forms of retinitis pigmentosa","author":"Heckenlively","year":"1988"},{"key":"10.1016\/j.ymthe.2020.11.029_bib5","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.preteyeres.2008.05.003","article-title":"Leber congenital amaurosis: genes, proteins and disease mechanisms","volume":"27","author":"den Hollander","year":"2008","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2020.11.029_bib6","series-title":"GeneReviews","article-title":"RPE65-related Leber congenital amaurosis \/ early-onset severe retinal dystrophy","author":"Chao","year":"1993"},{"key":"10.1016\/j.ymthe.2020.11.029_bib7","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1167\/iovs.10-6106","article-title":"The phenotype of severe early childhood onset retinal dystrophy (SECORD) from mutation of RPE65 and differentiation from Leber congenital amaurosis","volume":"52","author":"Weleber","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ajhg.2011.12.019","article-title":"X-linked megalocornea caused by mutations in CHRDL1 identifies an essential role for ventroptin in anterior segment development","volume":"90","author":"Webb","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2020.11.029_bib9","doi-asserted-by":"crossref","first-page":"15751","DOI":"10.1016\/S0021-9258(18)82319-5","article-title":"Molecular cloning and expression of RPE65, a novel retinal pigment epithelium-specific microsomal protein that is post-transcriptionally regulated in\u00a0vitro","volume":"268","author":"Hamel","year":"1993","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2020.11.029_bib10","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1006\/geno.1994.1212","article-title":"The gene for the retinal pigment epithelium-specific protein RPE65 is localized to human 1p31 and mouse 3","volume":"20","author":"Hamel","year":"1994","journal-title":"Genomics"},{"key":"10.1016\/j.ymthe.2020.11.029_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/ng1097-139","article-title":"Mutations in RPE65 cause Leber\u2019s congenital amaurosis","volume":"17","author":"Marlhens","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2020.11.029_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1006\/abbi.1997.0276","article-title":"RPE65, the major retinal pigment epithelium microsomal membrane protein, associates with phospholipid liposomes","volume":"346","author":"Tsilou","year":"1997","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ymthe.2020.11.029_bib13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0076-6879(00)16758-8","article-title":"Genetic analysis of RPE65: from human disease to mouse model","volume":"316","author":"Redmond","year":"2000","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ymthe.2020.11.029_bib14","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/3813","article-title":"Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle","volume":"20","author":"Redmond","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2020.11.029_bib15","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1167\/iovs.18-23873","article-title":"A cross-sectional and longitudinal study of retinal sensitivity in RPE65-associated Leber congenital amaurosis","volume":"59","author":"Kumaran","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib16","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archopht.118.4.538","article-title":"Mutation analysis of 3 genes in patients with Leber congenital amaurosis","volume":"118","author":"Lotery","year":"2000","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ymthe.2020.11.029_bib17","doi-asserted-by":"crossref","first-page":"8623","DOI":"10.1073\/pnas.150236297","article-title":"Rapid restoration of visual pigment and function with oral retinoid in a mouse model of childhood blindness","volume":"97","author":"Van Hooser","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.11.029_bib18","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/ng1097-194","article-title":"Mutations in RPE65 cause autosomal recessive childhood-onset severe retinal dystrophy","volume":"17","author":"Gu","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2020.11.029_bib19","first-page":"2735","article-title":"Early-onset severe rod-cone dystrophy in young children with RPE65 mutations","volume":"41","author":"Lorenz","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib20","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1167\/iovs.08-2696","article-title":"Defining the residual vision in Leber congenital amaurosis caused by RPE65 mutations","volume":"50","author":"Jacobson","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib21","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1073\/pnas.0500646102","article-title":"Identifying photoreceptors in blind eyes caused by RPE65 mutations: prerequisite for human gene therapy success","volume":"102","author":"Jacobson","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.11.029_bib22","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1167\/iovs.07-1671","article-title":"A comprehensive clinical and biochemical functional study of a novel RPE65 hypomorphic mutation","volume":"49","author":"Lorenz","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib23","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1136\/bjophthalmol-2015-308019","article-title":"Preserved visual function in retinal dystrophy due to hypomorphic RPE65 mutations","volume":"100","author":"Hull","year":"2016","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2020.11.029_bib24","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ophtha.2004.08.023","article-title":"Clinical phenotypes in carriers of Leber congenital amaurosis mutations","volume":"112","author":"Galvin","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2020.11.029_bib25","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.ajo.2007.08.022","article-title":"Leber congenital amaurosis\u2014a model for efficient genetic testing of heterogeneous disorders: LXIV Edward Jackson Memorial Lecture","volume":"144","author":"Stone","year":"2007","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2020.11.029_bib26","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/jmg.40.9.709","article-title":"A Tyr368His RPE65 founder mutation is associated with variable expression and progression of early onset retinal dystrophy in 10 families of a genetically isolated population","volume":"40","author":"Yzer","year":"2003","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.ymthe.2020.11.029_bib27","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1089\/hum.2010.047","article-title":"Molecular anthropology meets genetic medicine to treat blindness in the North African Jewish population: human gene therapy initiated in Israel","volume":"21","author":"Banin","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2020.11.029_bib28","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.ymthe.2005.08.008","article-title":"Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness","volume":"12","author":"Acland","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.11.029_bib29","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/ng0501-92","article-title":"Gene therapy restores vision in a canine model of childhood blindness","volume":"28","author":"Acland","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2020.11.029_bib30","doi-asserted-by":"crossref","first-page":"e230","DOI":"10.1371\/journal.pmed.0040230","article-title":"Canine and human visual cortex intact and responsive despite early retinal blindness from RPE65 mutation","volume":"4","author":"Aguirre","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.ymthe.2020.11.029_bib31","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.1167\/iovs.10-5559","article-title":"Retinal disease in Rpe65-deficient mice: comparison to human Leber congenital amaurosis due to RPE65 mutations","volume":"51","author":"Caruso","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1006\/geno.1999.5754","article-title":"Retinal dystrophy of Swedish briard\/briard-beagle dogs is due to a 4-bp deletion in RPE65","volume":"57","author":"Veske","year":"1999","journal-title":"Genomics"},{"key":"10.1016\/j.ymthe.2020.11.029_bib33","first-page":"23","article-title":"Congenital stationary night blindness in the dog: common mutation in the RPE65 gene indicates founder effect","volume":"4","author":"Aguirre","year":"1998","journal-title":"Mol. Vis."},{"key":"10.1016\/j.ymthe.2020.11.029_bib34","first-page":"4593","article-title":"Continuing evaluation of gene therapy in the RPE65 mutant dog","volume":"43","author":"Acland","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib35","doi-asserted-by":"crossref","first-page":"E517","DOI":"10.1073\/pnas.1218933110","article-title":"Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement","volume":"110","author":"Cideciyan","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.11.029_bib36","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ymthe.2019.08.013","article-title":"Long-term structural outcomes of late-stage RPE65 gene therapy","volume":"28","author":"Gardiner","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.11.029_bib37","first-page":"4920","article-title":"Natural history of retinal function and structure in the Rpe65\u2212\/\u2212 murine model of Leber congenital amaurosis","volume":"44","author":"Aleman","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib38","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1167\/iovs.03-1230","article-title":"Impairment of the transient pupillary light reflex in Rpe65\u2212\/\u2212 mice and humans with Leber congenital amaurosis","volume":"45","author":"Aleman","year":"2004","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib39","first-page":"4293","article-title":"Genetics and phenotypes of RPE65 mutations in inherited retinal degeneration","volume":"41","author":"Thompson","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib40","first-page":"3529","article-title":"Cortical reorganization of peripheral vision induced by simulated central vision loss","volume":"39","author":"Chen","year":"2019","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib41","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.ophtha.2009.09.056","article-title":"Visual acuity in patients with Leber\u2019s congenital amaurosis and early childhood-onset retinitis pigmentosa","volume":"117","author":"Walia","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2020.11.029_bib42","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ajo.2018.09.024","article-title":"The natural history of inherited retinal dystrophy due to biallelic mutations in the RPE65 gene","volume":"199","author":"Chung","year":"2019","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2020.11.029_bib43","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00417-004-1020-x","article-title":"Longitudinal and cross-sectional study of patients with early-onset severe retinal dystrophy associated with RPE65 mutations","volume":"243","author":"Paunescu","year":"2005","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ymthe.2020.11.029_bib44","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1167\/iovs.12-11341","article-title":"Intervisit variability of visual parameters in Leber congenital amaurosis caused by RPE65 mutations","volume":"54","author":"Roman","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib45","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1167\/iovs.17-22905","article-title":"Severe loss of tritan color discrimination in RPE65 associated Leber congenital amaurosis","volume":"59","author":"Kumaran","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib46","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1167\/iovs.14-15895","article-title":"Pseudo-fovea formation after gene therapy for RPE65-LCA","volume":"56","author":"Cideciyan","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib47","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/archopht.120.1.55","article-title":"Clinical course and visual function in a family with mutations in the RPE65 gene","volume":"120","author":"Felius","year":"2002","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ymthe.2020.11.029_bib48","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1167\/iovs.09-3734","article-title":"Differential macular morphology in patients with RPE65-, CEP290-, GUCY2D-, and AIPL1-related Leber congenital amaurosis","volume":"51","author":"Pasadhika","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib49","doi-asserted-by":"crossref","first-page":"e3154","DOI":"10.1002\/jgm.3154","article-title":"RPE65 and retinal dystrophy: report of new and recurrent mutations","volume":"22","author":"Safari","year":"2020","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.ymthe.2020.11.029_bib50","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1097\/IAE.0000000000002681","article-title":"Longitudinal study of RPE65-associated inherited retinal degenerations","volume":"40","author":"Pierrache","year":"2020","journal-title":"Retina"},{"key":"10.1016\/j.ymthe.2020.11.029_bib51","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.ophtha.2010.09.005","article-title":"Fundus albipunctatus associated with compound heterozygous mutations in RPE65","volume":"118","author":"Schatz","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2020.11.029_bib52","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/s00417-005-0096-2","article-title":"Phenotype of three consanguineous Tunisian families with early-onset retinal degeneration caused by an R91W homozygous mutation in the RPE65 gene","volume":"244","author":"El Matri","year":"2006","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ymthe.2020.11.029_bib53","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1167\/iovs.07-0068","article-title":"Clinical and molecular genetics of Leber\u2019s congenital amaurosis: a multicenter study of Italian patients","volume":"48","author":"Simonelli","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib54","first-page":"1378","article-title":"Intervisit variability of visual parameters in Leber congenital amaurosis caused by RPE65 mutations. Invest. Ophthalmol","volume":"54","author":"Roman","year":"2013","journal-title":"Vis. Sci"},{"key":"10.1016\/j.ymthe.2020.11.029_bib55","first-page":"192","article-title":"A homozygous deletion in RPE65 in a small Sardinian family with autosomal recessive retinal dystrophy","volume":"6","author":"Poehner","year":"2000","journal-title":"Mol. Vis."},{"key":"10.1016\/j.ymthe.2020.11.029_bib56","doi-asserted-by":"crossref","first-page":"15123","DOI":"10.1073\/pnas.0706367104","article-title":"Human cone photoreceptor dependence on RPE65 isomerase","volume":"104","author":"Jacobson","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.11.029_bib57","doi-asserted-by":"crossref","first-page":"15112","DOI":"10.1073\/pnas.0807027105","article-title":"Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics","volume":"105","author":"Cideciyan","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.11.029_bib58","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.ophtha.2004.01.033","article-title":"Lack of fundus autofluorescence to 488 nanometers from childhood on in patients with early-onset severe retinal dystrophy associated with mutations in RPE65","volume":"111","author":"Lorenz","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2020.11.029_bib59","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1001\/jamaophthalmol.2020.2018","article-title":"Quantitative autofluorescence following gene therapy with voretigene neparvovec","volume":"138","author":"Levi","year":"2020","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.ymthe.2020.11.029_bib60","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10633-019-09745-z","article-title":"Late presentation of RPE65 retinopathy in three siblings","volume":"140","author":"Magliyah","year":"2020","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.ymthe.2020.11.029_bib61","doi-asserted-by":"crossref","first-page":"e112400","DOI":"10.1371\/journal.pone.0112400","article-title":"A novel mutation in the RPE65 gene causing Leber congenital amaurosis and its transcriptional expression in\u00a0vitro","volume":"9","author":"Mo","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2020.11.029_bib62","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1167\/iovs.08-2121","article-title":"Photoreceptor layer topography in children with Leber congenital amaurosis caused by RPE65 mutations","volume":"49","author":"Jacobson","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib63","doi-asserted-by":"crossref","first-page":"100827","DOI":"10.1016\/j.preteyeres.2019.100827","article-title":"Progress in treating inherited retinal diseases: early subretinal gene therapy clinical trials and candidates for future initiatives","volume":"77","author":"Garafalo","year":"2020","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2020.11.029_bib64","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1167\/iovs.07-0453","article-title":"Inner retinal abnormalities in X-linked retinitis pigmentosa with RPGR mutations","volume":"48","author":"Aleman","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib65","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.preteyeres.2010.04.002","article-title":"Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy","volume":"29","author":"Cideciyan","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2020.11.029_bib66","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1167\/iovs.15-16726","article-title":"Autofluorescence imaging with near-infrared excitation: normalization by reflectance to reduce signal from choroidal fluorophores","volume":"56","author":"Cideciyan","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib67","doi-asserted-by":"crossref","first-page":"13658","DOI":"10.1073\/pnas.0504167102","article-title":"Mutation of key residues of RPE65 abolishes its enzymatic role as isomerohydrolase in the visual cycle","volume":"102","author":"Redmond","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.11.029_bib68","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/ejhg.2011.86","article-title":"A dominant mutation in RPE65 identified by whole-exome sequencing causes retinitis pigmentosa with choroidal involvement","volume":"19","author":"Bowne","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2020.11.029_bib69","first-page":"626","article-title":"The clinical features of retinal disease due to a dominant mutation in RPE65","volume":"22","author":"Hull","year":"2016","journal-title":"Mol. Vis."},{"key":"10.1016\/j.ymthe.2020.11.029_bib70","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ajpath.2016.11.004","article-title":"A dominant mutation in Rpe65, D477G, delays dark adaptation and disturbs the visual cycle in the mutant knock-in mice","volume":"187","author":"Shin","year":"2017","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2020.11.029_bib71","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1093\/hmg\/ddy128","article-title":"Insights into the pathogenesis of dominant retinitis pigmentosa associated with a D477G mutation in RPE65","volume":"27","author":"Choi","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2020.11.029_bib72","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1080\/13816810.2018.1484929","article-title":"Two-year progression analysis of RPE65 autosomal dominant retinitis pigmentosa","volume":"39","author":"Jauregui","year":"2018","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.ymthe.2020.11.029_bib73","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/humu.23706","article-title":"Aberrant RNA splicing is the major pathogenic effect in a knock-in mouse model of the dominantly inherited c.1430A>G human RPE65 mutation","volume":"40","author":"Li","year":"2019","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymthe.2020.11.029_bib74","doi-asserted-by":"crossref","DOI":"10.1101\/mcs.a004952","article-title":"Phenotypic expansion of autosomal dominant retinitis pigmentosa associated with the D477G mutation in RPE65","volume":"6","author":"Jauregui","year":"2020","journal-title":"Cold Spring Harb. Mol. Case Stud."},{"key":"10.1016\/j.ymthe.2020.11.029_bib75","doi-asserted-by":"crossref","first-page":"e000462","DOI":"10.1136\/bmjophth-2020-000462","article-title":"Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy","volume":"5","author":"Kenna","year":"2020","journal-title":"BMJ Open Ophthalmol."},{"key":"10.1016\/j.ymthe.2020.11.029_bib76","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1093\/hmg\/ddp163","article-title":"Loss of cone photoreceptors caused by chromophore depletion is partially prevented by the artificial chromophore pro-drug, 9-cis-retinyl acetate","volume":"18","author":"Maeda","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2020.11.029_bib77","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1167\/iovs.09-3700","article-title":"Evaluation of 9-cis-retinyl acetate therapy in Rpe65\u2212\/\u2212 mice","volume":"50","author":"Maeda","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib78","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1001\/archophthalmol.2010.210","article-title":"Improvement of visual performance with intravitreal administration of 9-cis-retinal in Rpe65-mutant dogs","volume":"128","author":"Gearhart","year":"2010","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ymthe.2020.11.029_bib79","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1167\/iovs.12-11152","article-title":"QLT091001, a 9-cis-retinal analog, is well-tolerated by retinas of mice with impaired visual cycles","volume":"54","author":"Maeda","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib80","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(14)60153-7","article-title":"Oral 9-cis retinoid for childhood blindness due to Leber congenital amaurosis caused by RPE65 or LRAT mutations: an open-label phase 1b trial","volume":"384","author":"Koenekoop","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2020.11.029_bib81","doi-asserted-by":"crossref","first-page":"e0143846","DOI":"10.1371\/journal.pone.0143846","article-title":"Safety and proof-of-concept study of oral QLT091001 in retinitis pigmentosa due to inherited deficiencies of retinal pigment epithelial 65 protein (RPE65) or lecithin:retinol acyltransferase (LRAT)","volume":"10","author":"Scholl","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2020.11.029_bib82","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1517\/21678707.2015.1030393","article-title":"Improvement in vision: a new goal for treatment of hereditary retinal degenerations","volume":"3","author":"Jacobson","year":"2015","journal-title":"Expert Opin. Orphan Drugs"},{"key":"10.1016\/j.ymthe.2020.11.029_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamaophthalmol.2019.3914","article-title":"Utility of in\u00a0vitro mutagenesis of RPE65 protein for verification of mutational pathogenicity before gene therapy","volume":"137","author":"Yang","year":"2019","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.ymthe.2020.11.029_bib84","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ajo.2017.07.008","article-title":"Development of refractive errors\u2014what can we learn from inherited retinal dystrophies?","volume":"182","author":"Hendriks","year":"2017","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2020.11.029_bib85","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2214.1991.tb00684.x","article-title":"The age dependence of stereotyped behaviours in blind infants and preschoolers","volume":"17","author":"Tr\u00f6ster","year":"1991","journal-title":"Child Care Health Dev."},{"key":"10.1016\/j.ymthe.2020.11.029_bib86","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000105710","article-title":"[Diagnostic and prognostic importance of the electroretinogram in tapetoretinal degeneration with reduction of the visual field and hemeralopia]","volume":"14","author":"Franceschetti","year":"1954","journal-title":"Confin. Neurol."},{"key":"10.1016\/j.ymthe.2020.11.029_bib87","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.preteyeres.2017.08.004","article-title":"The mechanism of cone cell death in retinitis pigmentosa","volume":"62","author":"Campochiaro","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2020.11.029_bib88","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1167\/iovs.06-0764","article-title":"Macular pigment and lutein supplementation in ABCA4-associated retinal degenerations","volume":"48","author":"Aleman","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib89","first-page":"1873","article-title":"Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndrome","volume":"42","author":"Aleman","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib90","doi-asserted-by":"crossref","first-page":"158617","DOI":"10.1016\/j.bbalip.2020.158617","article-title":"The macular carotenoids: a biochemical overview","volume":"1865","author":"Arunkumar","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.ymthe.2020.11.029_bib91","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.preteyeres.2015.10.003","article-title":"Lutein, zeaxanthin, and meso-zeaxanthin: the basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease","volume":"50","author":"Bernstein","year":"2016","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2020.11.029_bib92","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.preteyeres.2011.11.001","article-title":"The susceptibility of the retina to photochemical damage from visible light","volume":"31","author":"Hunter","year":"2012","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2020.11.029_bib93","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1073\/pnas.0408892102","article-title":"In\u00a0vivo dynamics of retinal injury and repair in the rhodopsin mutant dog model of human retinitis pigmentosa","volume":"102","author":"Cideciyan","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.11.029_bib94","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1364\/JOSAA.24.001457","article-title":"Reduced-illuminance autofluorescence imaging in ABCA4-associated retinal degenerations","volume":"24","author":"Cideciyan","year":"2007","journal-title":"J.\u00a0Opt. Soc. Am. A Opt. Image Sci. Vis."},{"key":"10.1016\/j.ymthe.2020.11.029_bib95","first-page":"1689","article-title":"An optimized adeno-associated virus (AAV) for treatment of Leber congenital amaurosis (LCA-RPE65)","volume":"48","author":"Bennett","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib96","first-page":"2857","article-title":"Real-time, noninvasive in\u00a0vivo assessment of adeno-associated virus-mediated retinal transduction","volume":"38","author":"Bennett","year":"1997","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib97","doi-asserted-by":"crossref","first-page":"9920","DOI":"10.1073\/pnas.96.17.9920","article-title":"Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina","volume":"96","author":"Bennett","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.11.029_bib98","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ymthe.2003.11.013","article-title":"In utero gene therapy rescues vision in a murine model of congenital blindness","volume":"9","author":"Dejneka","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.11.029_bib99","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1167\/iovs.05-0965","article-title":"RPE65 gene delivery restores isomerohydrolase activity and prevents early cone loss in Rpe65\u2212\/\u2212 mice","volume":"47","author":"Chen","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib100","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1023\/A:1024431827812","article-title":"Gene transfer in the RPE65 null mutation dog: relationship between construct volume, visual behavior and electroretinographic (ERG) results","volume":"107","author":"Ford","year":"2003","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.ymthe.2020.11.029_bib101","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/978-1-4615-0067-4_54","article-title":"Functional and structural evaluation after AAV.RPE65 gene transfer in the canine model of Leber\u2019s congenital amaurosis","volume":"533","author":"Narfstr\u00f6m","year":"2003","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ymthe.2020.11.029_bib102","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMoa0802315","article-title":"Safety and efficacy of gene transfer for Leber\u2019s congenital amaurosis","volume":"358","author":"Maguire","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2020.11.029_bib103","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/sj.mt.6300389","article-title":"Reversal of blindness in animal models of Leber congenital amaurosis using optimized AAV2-mediated gene transfer","volume":"16","author":"Bennicelli","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.11.029_bib104","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(09)61836-5","article-title":"Age-dependent effects of RPE65 gene therapy for Leber\u2019s congenital amaurosis: a phase 1 dose-escalation trial","volume":"374","author":"Maguire","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2020.11.029_bib105","doi-asserted-by":"crossref","first-page":"120ra15","DOI":"10.1126\/scitranslmed.3002865","article-title":"AAV2 gene therapy readministration in three adults with congenital blindness","volume":"4","author":"Bennett","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2020.11.029_bib106","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/mt.2009.277","article-title":"Gene therapy for Leber\u2019s congenital amaurosis is safe and effective through 1.5 years after vector administration","volume":"18","author":"Simonelli","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.11.029_bib107","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(16)30371-3","article-title":"Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial","volume":"388","author":"Bennett","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2020.11.029_bib108","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.ophtha.2017.01.029","article-title":"The role of the human visual cortex in assessment of the long-term durability of retinal gene therapy in follow-on RPE65 clinical trial patients","volume":"124","author":"Ashtari","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2020.11.029_bib109","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2020.11.029_bib110","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.ophtha.2019.06.017","article-title":"Efficacy, safety, and durability of voretigene neparvovec-rzyl in RPE65 mutation-associated inherited retinal dystrophy: results of phase 1 and 3 trials","volume":"126","author":"Maguire","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2020.11.029_bib111","series-title":"Phase 3 trial of AAV2-hRPE65v2 (SPK-RPE65) to treat RPE65 mutation-associated inherited retinal dystrophies","author":"Russell","year":"2016"},{"key":"10.1016\/j.ymthe.2020.11.029_bib112","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1089\/hum.2008.107","article-title":"Treatment of Leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial","volume":"19","author":"Hauswirth","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2020.11.029_bib113","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1089\/hum.2009.086","article-title":"Human RPE65 gene therapy for Leber congenital amaurosis: persistence of early visual improvements and safety at 1 year","volume":"20","author":"Cideciyan","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2020.11.029_bib114","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/archophthalmol.2011.298","article-title":"Gene therapy for Leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years","volume":"130","author":"Jacobson","year":"2012","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ymthe.2020.11.029_bib115","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa1412965","article-title":"Improvement and decline in vision with gene therapy in childhood blindness","volume":"372","author":"Jacobson","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2020.11.029_bib116","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1056\/NEJMoa0802268","article-title":"Effect of gene therapy on visual function in Leber\u2019s congenital amaurosis","volume":"358","author":"Bainbridge","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2020.11.029_bib117","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa1414221","article-title":"Long-term effect of gene therapy on Leber\u2019s congenital amaurosis","volume":"372","author":"Bainbridge","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2020.11.029_bib118","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.ophtha.2016.03.003","article-title":"Results at 2 years after gene therapy for RPE65-deficient Leber congenital amaurosis and severe early-childhood-onset retinal dystrophy","volume":"123","author":"Weleber","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2020.11.029_bib119","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1089\/hum.2018.014","article-title":"Results at 5 years after gene therapy for RPE65-deficient retinal dystrophy","volume":"29","author":"Pennesi","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2020.11.029_bib120","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ymthe.2017.09.014","article-title":"Safety and long-term efficacy of AAV4 gene therapy in patients with RPE65 Leber congenital amaurosis","volume":"26","author":"Le Meur","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.11.029_bib121","doi-asserted-by":"crossref","first-page":"8381","DOI":"10.1167\/iovs.11-7973","article-title":"Histopathology and functional correlations in a patient with a mutation in RPE65, the gene for retinol isomerase","volume":"52","author":"Bonilha","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib122","first-page":"4122","article-title":"Year 2 results for a phase 3 trial of voretigene neparvovec in biallelic RPE65-mediated inherited retinal disease","volume":"58","author":"Russell","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib123","unstructured":"Maguire, A., Russell, S., Bennett, J., Chung, D., Wellman, J., and High, K. (2015). Phase 3 trial of AAV2-hRPE65v2 (SPK-RPE65) to treat RPE65 mutation-associated inherited retinal dystrophies. Presented at: American Academy of Ophthalmology annual meeting. Nov. 14, 2015; Las Vegas."},{"key":"10.1016\/j.ymthe.2020.11.029_bib124","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/13816810.2018.1533027","article-title":"Gene therapy for RPE65-related retinal disease","volume":"39","author":"Miraldi Utz","year":"2018","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.ymthe.2020.11.029_bib125","doi-asserted-by":"crossref","first-page":"21ra16","DOI":"10.1126\/scitranslmed.3000659","article-title":"Safety and efficacy of subretinal readministration of a viral vector in large animals to treat congenital blindness","volume":"2","author":"Amado","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2020.11.029_bib126","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1444-0938.2006.00050.x","article-title":"Measuring mobility performance: experience gained in designing a mobility course","volume":"89","author":"Leat","year":"2006","journal-title":"Clin. Exp. Optom."},{"key":"10.1016\/j.ymthe.2020.11.029_bib127","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/ceo.13022","article-title":"Novel mobility test to assess functional vision in patients with inherited retinal dystrophies","volume":"46","author":"Chung","year":"2018","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ymthe.2020.11.029_bib128","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/cxo.13004","article-title":"Orientation and mobility outcome measures","volume":"103","author":"Chang","year":"2020","journal-title":"Clin. Exp. Optom."},{"key":"10.1016\/j.ymthe.2020.11.029_bib129","first-page":"1578","article-title":"Psychometric evaluation of a modified version of the Visual Function Questionnaire using data from a phase III trial in biallelic RPE65 mutation-associated inherited retinal dystrophy","volume":"61","author":"Banhazi","year":"2020","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib130","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1167\/iovs.61.5.30","article-title":"Treatment potential for LCA5-associated Leber congenital amaurosis","volume":"61","author":"Uyhazi","year":"2020","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib131","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ophtha.2016.10.022","article-title":"Natural history of the central structural abnormalities in choroideremia: a prospective cross-sectional study","volume":"124","author":"Aleman","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2020.11.029_bib132","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1167\/iovs.05-0533","article-title":"Cone opsin mislocalization in Rpe65\u2212\/\u2212 mice: a defect that can be corrected by 11-cis retinal","volume":"46","author":"Rohrer","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib133","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/gt.2012.63","article-title":"RPE65 gene therapy slows cone loss in Rpe65-deficient dogs","volume":"20","author":"Mowat","year":"2013","journal-title":"Gene Ther"},{"key":"10.1016\/j.ymthe.2020.11.029_bib134","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1167\/iovs.17-21930","article-title":"Early-onset progressive degeneration of the area centralis in RPE65-deficient dogs","volume":"58","author":"Mowat","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib135","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1056\/NEJMc1509501","article-title":"Visual acuity after retinal gene therapy for choroideremia","volume":"374","author":"Edwards","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2020.11.029_bib136","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/hum.2016.117","article-title":"Lentiviral vector gene transfer of endostatin\/angiostatin for macular degeneration (GEM) study","volume":"28","author":"Campochiaro","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2020.11.029_bib137","first-page":"4485","article-title":"AAV2-hCHM subretinal delivery to the macula in choroideremia: preliminary six month safety results of an ongoing phase I\/II gene therapy trial","volume":"58","author":"Aleman","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib138","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1167\/iovs.17-22402","article-title":"Subretinal injection for gene therapy does not cause clinically significant outer nuclear layer thinning in normal primate foveae","volume":"58","author":"Ochakovski","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib139","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.omtm.2019.08.011","article-title":"Safety of same-eye subretinal sequential readministration of AAV2-hRPE65v2 in non-human primates","volume":"15","author":"Weed","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2020.11.029_bib140","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/eye.2017.158","article-title":"Technique of retinal gene therapy: delivery of viral vector into the subretinal space","volume":"31","author":"Xue","year":"2017","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.ymthe.2020.11.029_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2018.08.038","article-title":"The blunt end: surgical challenges of gene therapy for inherited retinal diseases","volume":"196","author":"Davis","year":"2018","journal-title":"Am. J. Ophthalmol."},{"issue":"Suppl 1","key":"10.1016\/j.ymthe.2020.11.029_bib142","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/IAE.0000000000002609","article-title":"Surgical technique for subretinal gene therapy in humans with inherited retinal degeneration","volume":"39","author":"Davis","year":"2019","journal-title":"Retina"},{"issue":"Suppl 1","key":"10.1016\/j.ymthe.2020.11.029_bib143","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/IAE.0000000000001646","article-title":"Intraoperative use of microscope-integrated optical coherence tomography for subretinal gene therapy delivery","volume":"39","author":"Gregori","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.ymthe.2020.11.029_bib144","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.omtm.2020.01.002","article-title":"Suprachoroidal and subretinal injections of AAV using transscleral microneedles for retinal gene delivery in nonhuman primates","volume":"16","author":"Yiu","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2020.11.029_bib145","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1136\/bjophthalmol-2014-305294","article-title":"Intraoperative optical coherence tomography using the RESCAN 700: preliminary results from the DISCOVER study","volume":"98","author":"Ehlers","year":"2014","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2020.11.029_bib146","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1089\/hgtb.2016.086","article-title":"Evaluation of an optimized injection system for retinal gene therapy in human patients","volume":"27","author":"Fischer","year":"2016","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.ymthe.2020.11.029_bib147","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00006982-198909010-00008","article-title":"Retinal attachment to the pigment epithelium. Linkage through an extracellular sheath surrounding cone photoreceptors","volume":"9","author":"Hollyfield","year":"1989","journal-title":"Retina"},{"key":"10.1016\/j.ymthe.2020.11.029_bib148","first-page":"708","article-title":"[Long-term enlargement of laser photocoagulation scars after treatment of choroidal neovascularization]","volume":"106","author":"Matsuda","year":"2002","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"10.1016\/j.ymthe.2020.11.029_bib149","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1167\/iovs.16-19302","article-title":"Automated light- and dark-adapted perimetry for evaluating retinitis pigmentosa: filling a need to accommodate multicenter clinical trials","volume":"57","author":"McGuigan","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib150","doi-asserted-by":"crossref","first-page":"N51","DOI":"10.1088\/0967-3334\/28\/8\/N02","article-title":"Full-field stimulus testing (FST) to quantify visual perception in severely blind candidates for treatment trials","volume":"28","author":"Roman","year":"2007","journal-title":"Physiol. Meas."},{"key":"10.1016\/j.ymthe.2020.11.029_bib151","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10633-009-9204-7","article-title":"Psychophysical assessment of low visual function in patients with retinal degenerative diseases (RDDs) with the Diagnosys full-field stimulus threshold (D-FST)","volume":"119","author":"Klein","year":"2009","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.ymthe.2020.11.029_bib152","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.exer.2004.09.008","article-title":"Quantifying rod photoreceptor-mediated vision in retinal degenerations: dark-adapted thresholds as outcome measures","volume":"80","author":"Roman","year":"2005","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ymthe.2020.11.029_bib153","series-title":"FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss","year":"2017"},{"key":"10.1016\/j.ymthe.2020.11.029_bib154","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0161-6420(84)34247-6","article-title":"The morphological development of the human fovea","volume":"91","author":"Hendrickson","year":"1984","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2020.11.029_bib155","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.ajo.2012.05.004","article-title":"Maturation of the human fovea: correlation of spectral-domain optical coherence tomography findings with histology","volume":"154","author":"Vajzovic","year":"2012","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2020.11.029_bib156","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fnins.2017.00174","article-title":"Retinal gene therapy: surgical vector delivery in the translation to clinical trials","volume":"11","author":"Ochakovski","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib157","doi-asserted-by":"crossref","first-page":"e0209996","DOI":"10.1371\/journal.pone.0209996","article-title":"The influence of subretinal injection pressure on the microstructure of the monkey retina","volume":"13","author":"Takahashi","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2020.11.029_bib158","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archophthalmol.2011.295","article-title":"Functional and anatomic consequences of subretinal dosing in the cynomolgus macaque","volume":"130","author":"Nork","year":"2012","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ymthe.2020.11.029_bib159","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1167\/iovs.02-0633","article-title":"Cone photoreceptor recovery after experimental detachment and reattachment: an immunocytochemical, morphological, and electrophysiological study","volume":"44","author":"Sakai","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib160","doi-asserted-by":"crossref","first-page":"189ra76","DOI":"10.1126\/scitranslmed.3005708","article-title":"In\u00a0vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous","volume":"5","author":"Dalkara","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2020.11.029_bib161","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1089\/hum.2016.085","article-title":"Highly efficient delivery of adeno-associated viral vectors to the primate retina","volume":"27","author":"Boye","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2020.11.029_bib162","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96029","article-title":"Noninvasive gene delivery to foveal cones for vision restoration","volume":"3","author":"Khabou","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2020.11.029_bib163","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ymthe.2018.08.003","article-title":"Breaking and sealing barriers in retinal gene therapy","volume":"26","author":"Miller","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.11.029_bib164","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.ymthe.2018.05.025","article-title":"Retinal AAV8-RS1 gene therapy for X-linked retinoschisis: initial findings from a Phase I\/IIa trial by intravitreal delivery","volume":"26","author":"Cukras","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.11.029_bib165","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41591-018-0295-0","article-title":"Effect of an intravitreal antisense oligonucleotide on vision in Leber congenital amaurosis due to a photoreceptor cilium defect","volume":"25","author":"Cideciyan","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2020.11.029_bib166","article-title":"Genetic rescue of X-linked retinoschisis mouse (Rs1-\/y) retina induces quiescence of the retinal microglial inflammatory state following AAV8-RS1 gene transfer and identifies gene networks underlying retinal recovery","author":"Vijayasarathy","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2020.11.029_bib167","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ymthe.2016.10.008","article-title":"Improved intravitreal AAV-mediated inner retinal gene transduction after surgical internal limiting membrane peeling in cynomolgus monkeys","volume":"25","author":"Takahashi","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.11.029_bib168","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1167\/iovs.17-22494","article-title":"Humoral immune response after intravitreal but not after subretinal AAV8 in primates and patients","volume":"59","author":"Reichel","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib169","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.1167\/iovs.17-22473","article-title":"Superior retinal gene transfer and biodistribution profile of subretinal versus intravitreal delivery of AAV8 in nonhuman primates","volume":"58","author":"Seitz","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib170","doi-asserted-by":"crossref","first-page":"19629","DOI":"10.1073\/pnas.2008211117","article-title":"Shedding new light on the generation of the visual chromophore","volume":"117","author":"Palczewski","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.11.029_bib171","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1124\/mol.117.111294","article-title":"Retinal-chitosan conjugates effectively deliver active chromophores to retinal photoreceptor cells in blind mice and dogs","volume":"93","author":"Gao","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ymthe.2020.11.029_bib172","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3390\/cells9030630","article-title":"Innate and autoimmunity in the pathogenesis of inherited retinal dystrophy","volume":"9","author":"Hollingsworth","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ymthe.2020.11.029_bib173","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.3389\/fimmu.2020.01463","article-title":"Microglia inhibition delays retinal degeneration due to MerTK phagocytosis receptor deficiency","volume":"11","author":"Lew","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2020.11.029_bib174","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-3-030-27378-1_29","article-title":"Increased protein citrullination as a trigger for resident immune system activation, intraretinal inflammation, and promotion of anti-retinal autoimmunity: intersecting paths in retinal degenerations of potential therapeutic relevance. Adv","volume":"1185","author":"Iannaccone","year":"2019","journal-title":"Exp. Med. Biol"},{"key":"10.1016\/j.ymthe.2020.11.029_bib175","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1167\/iovs.61.10.25","article-title":"Suppression of cGMP-dependent photoreceptor cytotoxicity with mycophenolate is neuroprotective in murine models of retinitis pigmentosa","volume":"61","author":"Yang","year":"2020","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib176","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/gt.2016.66","article-title":"Development of an optimized AAV2\/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65","volume":"23","author":"Georgiadis","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2020.11.029_bib177","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/gt.2011.155","article-title":"Optogenetic therapy for retinitis pigmentosa","volume":"19","author":"Busskamp","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2020.11.029_bib178","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.15252\/emmm.201404077","article-title":"Efficient transduction and optogenetic stimulation of retinal bipolar cells by a synthetic adeno-associated virus capsid and promoter","volume":"6","author":"Cronin","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2020.11.029_bib179","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nn.2117","article-title":"Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration","volume":"11","author":"Lagali","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ymthe.2020.11.029_bib180","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1016\/j.ophtha.2016.06.049","article-title":"Five-year safety and performance results from the argus ii retinal prosthesis system clinical trial","volume":"123","author":"da Cruz","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2020.11.029_bib181","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.ophtha.2015.04.032","article-title":"Long-term results from an epiretinal prosthesis to restore sight to the blind","volume":"122","author":"Ho","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2020.11.029_bib182","unstructured":"Aleman, T.S., Maguire, A.M., and Bennett, J. (2020). Chapter 28: Gene therapy. In: Pediatric Retina, Third Edition, M.E. Hartnett, ed. (Wolters Kluwer), pp. 189\u2013217."},{"key":"10.1016\/j.ymthe.2020.11.029_bib183","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ymthe.2018.02.009","article-title":"Safety first: perspective on patient-centered development of AAV gene therapy products","volume":"26","author":"Byrne","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.11.029_bib184","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/tvst.9.7.2","article-title":"Advancing clinical trials for inherited retinal diseases: recommendations from the second Monaciano Symposium","volume":"9","author":"Thompson","year":"2020","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.ymthe.2020.11.029_bib185","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1172\/JCI57377","article-title":"The human visual cortex responds to gene therapy-mediated recovery of retinal function","volume":"121","author":"Ashtari","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2020.11.029_bib186","doi-asserted-by":"crossref","first-page":"296ra110","DOI":"10.1126\/scitranslmed.aaa8791","article-title":"Plasticity of the human visual system after retinal gene therapy in patients with Leber\u2019s congenital amaurosis","volume":"7","author":"Ashtari","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2020.11.029_bib187","first-page":"1130","article-title":"Short-term assessment of subfoveal injection of AAV2-hCHM gene augmentation in choroideremia using adaptive optics ophthalmoscopy","volume":"61","author":"Wolfing Morgan","year":"2020","journal-title":"Invest. Ophthalmol. Vis. Sci."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001620306559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001620306559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:59:08Z","timestamp":1761501548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001620306559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":187,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1525001620306559"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2020.11.029","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Perspective: Treating RPE65-Associated Retinal Dystrophy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2020.11.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}